Results 11 to 20 of about 3,924 (164)

Dapsone Syndrome

Journal of Marine Medical Society, 2016
Introduction: Dapsone syndrome is a distinct hypersensitivity reaction characterized by skin rash, fever, generalized lymphadenopathy, hepatosplenomegaly and hepatitis which subside with cessation of dapsone therapy.
J Sridhar
doaj   +2 more sources

Dapsone – mechanism of action, safety of use and the role in the treatment of bullous pemphigoid according to current recommendations

Przegląd Dermatologiczny, 2016
Dapsone has been used in the treatment of bullous pemphigoid (BP) for over 50 years. According to the 2015 European Recommendations, the treatment of choice in BP are potent topical corticosteroids. In this article, we present data from the literature on
Magdalena Żychowska, Aleksandra Batycka-Baran, Jacek Szepietowski, Wojciech Baran   +3 more
doaj   +2 more sources

Methemoglobinemia and dapsone levels in patients with leprosy [PDF]

Brazilian Journal of Infectious Diseases, 2010
The objective of this work was to determine the methemoglobinemia and correlate with dapsone levels in multibacillary leprosy patients under leprosy multi-drug therapy. Thirty patients with laboratory and clinical diagnosis of multibacillary leprosy were
Jose Luiz Fernandes Vieira, Juan Gonzalo Bardarez Riveira, Ana de Nazaré Silva Martins, Jorge Pereira da Silva, Claudio Guedes Salgado   +4 more
doaj   +2 more sources

Adverse reactions in leprosy patients who underwent dapsone multidrug therapy: a retrospective study

Clinical Pharmacology: Advances and Applications, 2017
Sanjeev Guragain,1 Namrata Upadhayay,2 Bishwa Mohan Bhattarai3 1Department of Pharmacology, Gandaki Medical College Teaching Hospital and Research Centre, Lekhnath, 2Department of Physiology, Gandaki Medical College Teaching Hospital and Research ...
Guragain S, Upadhayay N, Bhattarai BM
doaj   +1 more source

Development and characterization of a new oral dapsone nanoemulsion system: permeability and in silico bioavailability studies

International Journal of Nanomedicine, 2012
Lidiane M Monteiro,1 Viviane F Lione,1 Flavia A do Carmo,1 Lilian H do Amaral,1 Julianna H da Silva,2 Luiz E Nasciutti,2 Carlos R Rodrigues,1 Helena C Castro,3 Valeria P de Sousa,1 Lucio M Cabral11Faculdade de Farmácia, Universidade Federal do
Monteiro LM, Lione VF, do Carmo FA, do Amaral LH, da Silva JH, Nasciutti LE, Rodrigues CR, Castro HC, de Sousa VP, Cabral LM   +9 more
doaj   +1 more source

An unusual case of dapsone syndrome

Indian Dermatology Online Journal, 2011
Dapsone, a potent antiparasitic and anti-inflammatory compound, is mainly used in the treatment of leprosy and a variety of blistering skin diseases.
Mary Grace
doaj   +2 more sources

Cimetidine improves the therapeutic/toxic ratio of dapsone in patients on chronic dapsone therapy

, 1995
We have previously shown that cimetidine, given concurrently for 2 weeks to patients on chronic dapsone therapy, reduced methaemoglobinaemia by inhibiting the formation of the toxic hydroxylamine metabolite of dapsone. The aim of the present study was to
Friedmann, P. S., Chu, P., Rhodes, L. E.; id_orcid, Park, B. K., Tingle, M. D., Verbov, J. L.   +5 more
core   +10 more sources

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

Dapsone

Dermatology Online Journal, 2002
Dapsone (4,4'-diaminodiphenylsulfone, DDS) was synthesized a century ago and continues to be a powerful therapeutic tool in many skin diseases. We have tried to retrieve and present the available knowledge and relevant information on this old but still very useful drug with the hope of encouraging and guiding practicing dermatologists to adapt it for ...
Wolf, Ronni, Matz, Hagit, Orion, Edith, Tuzun, Binnur, Tuzun, Yalcin   +4 more
openaire   +4 more sources

Dapsone-induced methemoglobinemia and hemolysis in a woman without G6PD deficiency presenting with idiopathic urticaria

, 2022
The appearance of bite cells associated with methemoglobinemia can be caused by oxidizing drugs such as dapsone in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency or high drug serum levels. Bite cells are often pathognomonic for oxidant
Gandelman, Jocelyn S, Geere, Mimansa, Maham Awan (14191156), Pearson, Hadley J, Hu, Yang, Yang Hu (315392), Andrew D. Leavitt (14191159), Laura E. Brown (9241973), Brown, Laura E, Mimansa Geere (14191153), Scott C. Kogan (14191168), Kogan, Scott C, Jocelyn S. Gandelman (14191165), Awan, Maham, Leavitt, Andrew D, Hadley J. Pearson (14191162)   +15 more
core   +1 more source